Pfizer said on Thursday it will stop global development and commercialization of its hemophilia gene therapy, Beqvez, citing ...

The respiratory syncytial virus (RSV) vaccine produced strong immune responses in older adults during its first two seasons of use, according to a new study.

Penmenvy, which protects against five common types of disease-causing bacteria, is cleared for use in people aged 10 through ...

Learn how analytical methodologies can be used to identify RSV pre- and post-fusion proteins for vaccine development.

There have been calls for caution when it comes to the use of Pfizer’s respiratory syncytial virus (RSV) vaccine in pregnant women, ahead of an FDA advisory committee meeting scheduled to review ...

By elucidating the impact of specific bacterial profiles on both the severity of RSV infections and their long-term health consequences, the study paves the way for potential new strategies in ...

Add videos to your saved list and come back to them any time.

A nationwide surge in flu, COVID-19, RSV and norovirus infections is fueling concerns of a possible virus "quademic." Or is it just winter? The three respiratory viruses plus norovirus ...